177 related articles for article (PubMed ID: 32990407)
1. Chemical signature of colorectal cancer: case-control study for profiling the breath print.
Altomare DF; Picciariello A; Rotelli MT; De Fazio M; Aresta A; Zambonin CG; Vincenti L; Trerotoli P; De Vietro N
BJS Open; 2020 Sep; 4(6):1189-99. PubMed ID: 32990407
[TBL] [Abstract][Full Text] [Related]
2. Exhaled volatile organic compounds identify patients with colorectal cancer.
Altomare DF; Di Lena M; Porcelli F; Trizio L; Travaglio E; Tutino M; Dragonieri S; Memeo V; de Gennaro G
Br J Surg; 2013 Jan; 100(1):144-50. PubMed ID: 23212621
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
4. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
5. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
6. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
[TBL] [Abstract][Full Text] [Related]
7. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
[TBL] [Abstract][Full Text] [Related]
9. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.
Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A
Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
11. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
12. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
13. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer Diagnosis through Breath Test Using a Portable Breath Analyzer-Preliminary Data.
Picciariello A; Dezi A; Vincenti L; Spampinato MG; Zang W; Riahi P; Scott J; Sharma R; Fan X; Altomare DF
Sensors (Basel); 2024 Apr; 24(7):. PubMed ID: 38610554
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
[TBL] [Abstract][Full Text] [Related]
16. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
17. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.
Peng G; Hakim M; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Tisch U; Haick H
Br J Cancer; 2010 Aug; 103(4):542-51. PubMed ID: 20648015
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
Hanna GB; Boshier PR; Markar SR; Romano A
JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
[TBL] [Abstract][Full Text] [Related]
19. Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
Di Gilio A; Catino A; Lombardi A; Palmisani J; Facchini L; Mongelli T; Varesano N; Bellotti R; Galetta D; de Gennaro G; Tangaro S
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429446
[TBL] [Abstract][Full Text] [Related]
20. Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction.
Küppers L; Holz O; Schuchardt S; Gottlieb J; Fuge J; Greer M; Hohlfeld JM
J Breath Res; 2018 Jun; 12(3):036023. PubMed ID: 29771243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
